BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20929443)

  • 21. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
    Ryan MC; Desmond PV; Slavin JL; Congiu M
    J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
    Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG
    Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH; Jung DY; Kim HR; Jung MH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
    McPherson S; Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
    J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.
    Nakamuta M; Fujino T; Yada R; Yada M; Yasutake K; Yoshimoto T; Harada N; Higuchi N; Kato M; Kohjima M; Taketomi A; Maehara Y; Nakashima M; Kotoh K; Enjoji M
    Int J Mol Med; 2009 May; 23(5):603-8. PubMed ID: 19360318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα.
    Kim DI; Park MJ; Lim SK; Park JI; Yoon KC; Han HJ; Gustafsson JÅ; Lim JH; Park SH
    Diabetes; 2015 Jan; 64(1):60-71. PubMed ID: 25187371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
    Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
    Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis.
    Moriishi K; Mochizuki R; Moriya K; Miyamoto H; Mori Y; Abe T; Murata S; Tanaka K; Miyamura T; Suzuki T; Koike K; Matsuura Y
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1661-6. PubMed ID: 17234812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.
    Ahn SB; Jang K; Jun DW; Lee BH; Shin KJ
    Dig Dis Sci; 2014 Dec; 59(12):2975-82. PubMed ID: 25102981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
    Patra T; Sasaki R; Meyer K; Ray RB; Ray R
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.
    Li Q; Li L; Wang F; Chen J; Zhao Y; Wang P; Nilius B; Liu D; Zhu Z
    Pflugers Arch; 2013 Sep; 465(9):1303-16. PubMed ID: 23605066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
    Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
    Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
    Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
    J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Hepatology; 2008 Sep; 48(3):770-81. PubMed ID: 18752326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.
    Zhong D; Huang G; Zhang Y; Zeng Y; Xu Z; Zhao Y; He X; He F
    Cell Signal; 2013 Jun; 25(6):1429-37. PubMed ID: 23499676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional cross-talk between liver X receptor-α and constitutive androstane receptor links lipogenesis and xenobiotic responses.
    Zhai Y; Wada T; Zhang B; Khadem S; Ren S; Kuruba R; Li S; Xie W
    Mol Pharmacol; 2010 Oct; 78(4):666-74. PubMed ID: 20592274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.